Leidos (United States)

2026 · facilities

Structural and mechanistic analysis of KRAS, NRAS, and Rap1A signaling complexes with regulators, effectors, and small-molecule modulators

Dhirendra Simanshu · Leidos (United States) · funded by U.S. Department of Energy

2025–2026 · contract · N01

DCP - Clinical Trials Regulatory & Monitoring Support for US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$500k

2025–2028 · contract · N01

PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATE

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$794.8k

2025–2026 · contract · N01

DCEG- Repository Services for epidemiology studies

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$878.5k

2025–2026 · contract · N01

DCCPS - NCCR Data Platform Supplement

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$120.5k

2025–2028 · contract · N01

STABILITY STUDY SUPPORT OF R-VK4-116

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$98.5k

2025–2026 · contract · N01

DCP- Cancer Immunoprevention Laboratory Support

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.2M

2025–2026 · contract · N01

DCEG- GWAS Studies

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.1M

2025–2026 · contract · N01

HPV Serology

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.3M

2025–2030 · contract · N01

LEAD OPTIMIZATION OF A LONG NON-CODING RNA (LNCRNA) AS A POTENTIAL LIPID- AND GLUCOSE-LOWERING THERAPEUTIC

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$921.9k

2025–2026 · contract · N01

DCP - Clin Trl Info Mgt -DCP Enterprise System Knowledge Base (DESK)

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$640.6k

2025–2030 · contract · N01

MANUFACTURING PROCESS DEVELOPMENT OF 4-HB

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$917.7k

2025–2030 · contract · N02

FY25 TO-C REFURBISH ELEVATORS

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$4.3M

2025–2026 · contract · N01

FY25 FACILITIES TASK ORDER A - REPLACE WOOD STREET STEAM & CONDENSATE PIPING

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.9M

2025–2027 · contract · N01

FY25 FACILITIES TO G CONSTRUCTION OF BMP STRUCTURES FOR MDE STORM-WATER COMPLIANCE

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.2M

2025–2026 · contract · N01

CGH - Center for Global Health Data Analysis, Technical Support and Dialogues

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.1M

2025–2030 · contract · N01

DEVELOP, QUALIFY IMMUNOLOGICAL ASSAYS, AND PROVIDE CLINICAL SAMPLE TESTING FOR AAV-BASED GENE THERAPY CLINICAL CANDIDATES

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.5M

2025–2027 · contract · N01

FY25 TO-B

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.1M

2025–2026 · contract · N01

DCP - Biospecimen Processing and Trial Logistics

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.9M

2025–2030 · contract · N01

CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NES-100 AS A NASAL SPRAY OF A NEW ANALGESIC

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.3M

2025–2026 · contract · N01

NIEHS - Lung Microbiome Promotes Emphysema by Activating Lung Innate Immunity

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$25.1k

2025–2027 · contract · N01

EVALUATION OF IVO COMPOUNDS IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS MODEL

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$219.8k

2025–2027 · contract · N01

FY25 TO-H W3F1 RENOVATIONS

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.9M

2025–2028 · contract · N01

FY25 TASK ORDER D - BASE: WO 126680 B539 EAST BASEMENT SWITCHBOARDREPLACEMENT. OPTION 1: 126680A B539 WEST ATTIC SWITCHBOARDREPLACEMENT

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2M

2025–2026 · contract · N01

DCEG- Genotyping for epidemiology studies

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$5.7M

2025–2026 · contract · N01

DCEG- Molecular Assays for epidemiology studies

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.4M

2025–2028 · contract · N01

IPP NCI FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC) CONTRACT TO-F

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$2.5M

2025–2030 · contract · N01

COORDINATED FACILITIES REQUIREMENTS FOR FY25 - FACILITIES TO I

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$15.1M

2025–2026 · contract · N01

FY26 FFRDC LEASES

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$22M

2025–2026 · contract · N01

Division of Cancer Treatment and Diagnosis- Operational Task Order

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$41.6M

2025–2026 · contract · N01

MANUFACTURING CGMP GRADE HYDROXYCOBALAMINE

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$61.5k

2025–2027 · contract · N01

FY25 FACILITIES TO E - 126663 B539 MISC SAFETY UPGRADES

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.7M

2024–2026 · contract · N01

TO-I BUILDING 1021 2ND FLOOR AHU REPLACEMENT

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$3.1M

2024–2025 · contract · N01

FY24/FY25 FFRDC LEASES OPERATIONAL TASK ORDER

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$17M

2024–2025 · contract · N01

DCP - COPTRG Support [National Surgical Adjuvant Breast and Bowel Project (NSABP)

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$385k

2024–2025 · contract · N01

HCMI Searchable Catalog

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$105.6k

2024–2025 · contract · N01

Strategic Scientific Pilot Support

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$1.3M

2024–2027 · contract · N01

Clinical Trails to Evaluate H5N1 Influenza Variant Vaccines

Theresa Engel · Leidos (United States) · funded by National Institutes of Health

$8M

2024–2026 · contract · N01

FY24 FACILITIES TO C - 126610 B555 CHILLER VFD INSTALL

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$905.1k

2024–2026 · contract · N01

WORK ORDER 126643 B539 EXPAND IC SUITE

Lynn Briscoe · Leidos (United States) · funded by National Institutes of Health

$461.2k